Analystreport

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $62.00 price target on the stock.

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares  (KNSA) 
Last kiniksa pharmaceuticals international, plc - class a ordinary shares earnings: 8/12 04:02 pm Check Earnings Report